A machine learning model that emulates experts decision making in vancomycin initial dose planning
T. Matsuzaki, Y. Kato, H. Mizoguchi, K. Yamada
This study develops a machine learning model to emulate expert decision-making for vancomycin initial dosing, achieving comparable therapeutic outcomes to expert-recommended regimens.
bioRxiv · Sep 16, 2021Pharmacology & Toxicology